| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0360-3016(01)02808-5 |
| P698 | PubMed publication ID | 11955745 |
| P50 | author | Jaume Pahisa | Q47504426 |
| Rosa Abellana | Q56810029 | ||
| Jaume Ordi | Q59146714 | ||
| P2093 | author name string | Angeles Rovirosa | |
| Carlos Ascaso | |||
| Xavier Iglesias | |||
| Albert Biete | |||
| Begoña Mellado | |||
| Meritxell Arenas | |||
| Luis M Puig-Tintoré | |||
| José-Antonio Lejarcegui | |||
| Beatríz Armenteros | |||
| P2860 | cites work | Management of malignant, mixed mesodermal tumors of the uterus | Q38264116 |
| Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients | Q38553836 | ||
| Uterine sarcomas: a clinicopathologic study. | Q39616417 | ||
| The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma | Q39787004 | ||
| Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri | Q39977132 | ||
| Malignant mixed müllerian tumors of the uterus | Q40108713 | ||
| Effects of irradiation on mixed müllerian tumors of the uterus | Q40229476 | ||
| Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). | Q40964424 | ||
| Uterine sarcoma: analysis of prognostic variables in 71 cases | Q41774278 | ||
| Patterns of recurrence in malignant mixed müllerian tumor of the uterus | Q42053976 | ||
| Operative management of early invasive epidermoid carcinoma of the vulva | Q43890189 | ||
| The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer | Q44008529 | ||
| Uterine sarcoma in Israel: a study of 104 cases | Q44050686 | ||
| Uterine leiomyosarcoma: analysis of treatment failures and survival | Q44299069 | ||
| Stage I endometrial carcinoma: the importance of pathologic review in retrospective analyses | Q44698986 | ||
| Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study | Q44739811 | ||
| Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus | Q44741471 | ||
| Treatment of uterine sarcomas. | Q45939878 | ||
| Uterine carcinosarcomas: incidence and trends in management and survival | Q46161316 | ||
| Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage | Q46421539 | ||
| Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. | Q51033875 | ||
| Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. | Q53350550 | ||
| Mixed mesodermal sarcoma of the uterus. | Q54024729 | ||
| Retrospective analysis of 318 cases of uterine sarcoma | Q57650086 | ||
| Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma | Q59392022 | ||
| A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas | Q67325476 | ||
| Uterine sarcomas: natural history, treatment and prognosis | Q67390563 | ||
| Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma | Q67976015 | ||
| Aggressive stage I grade 1 endometrial carcinoma | Q68234114 | ||
| Clinicopathologic analysis of uterine malignant mixed müllerian tumors | Q69354863 | ||
| Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study | Q69395011 | ||
| Uterine sarcomas: prognostic factors and treatment modalities--study on 209 patients | Q69489431 | ||
| Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas | Q69801494 | ||
| A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study | Q69905277 | ||
| The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer | Q70070207 | ||
| Adjuvant therapy in mixed mullerian tumors of the uterus | Q70122645 | ||
| Uterine sarcoma: an analysis of 74 cases | Q70168555 | ||
| Leiomyosarcoma of the uterus | Q70533517 | ||
| The role of radiation therapy in the management of uterine sarcomas | Q70685916 | ||
| Uterine sarcomas: An analysis of 69 patients | Q71006145 | ||
| The clinical significance of invasion of veins by rectal cancer | Q71234334 | ||
| Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients | Q71259474 | ||
| Uterine sarcomas: A clinicopathologic study, 1965–1981 | Q72385734 | ||
| Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study | Q72948952 | ||
| Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin | Q73084898 | ||
| Uterine sarcoma in the south of Israel: study of 36 cases | Q73090129 | ||
| Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma | Q73549645 | ||
| Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments | Q74447121 | ||
| Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità | Q77373330 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | uterine neoplasm | Q56014517 |
| P304 | page(s) | 1320-1329 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages | |
| P478 | volume | 52 |
| Q35986639 | CD146 as an adverse prognostic factor in uterine sarcoma |
| Q33929694 | Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
| Q44214229 | Endometrial stromal sarcoma. Is there a place for radiotherapy? |
| Q53788771 | How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component? |
| Q35017944 | Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases |
| Q37253852 | Müllerian adenosarcoma of the uterine cervix with sarcomatous overgrowth: A case report of aggressive disease in a young patient |
| Q89774694 | Ovarian metastasis of Müllerian adenosarcoma of the cervix with sarcomatous overgrowth |
| Q59285626 | Pathologic prognostic factors in stage I–III uterine carcinosarcoma treated with postoperative radiotherapy |
| Q53539241 | Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. |
| Q36812603 | Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping |
| Q37392414 | Treatment of pure uterine sarcoma at the Institut Català D'Oncologia |
| Q92799056 | Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients |
| Q37338571 | Uterine adenosarcoma associated to lymphovascular emboli: a case report |
Search more.